Kevin H. Kerchner Named CEO of Aphena Pharma Solutions

7/9/2013 8:15:56 AM

Philadelphia, PA (PRWEB) July 09, 2013 -- Philadelphia-based Aphena Pharma Solutions, Inc., a leading pharmaceutical manufacturer and packaging provider in the United States, is pleased to announce Kevin H. Kerchner as its CEO. 

Aphena provides clients with a full range of solutions to address their pharmaceutical packaging and manufacturing requirements. With continued investment in people, technology, advanced packaging systems and rigorous cost control, they deliver solutions that are cost effective and comprehensive. Through every step in the development of a product, including concept, manufacturing, packaging and distribution, they provide clients with services and solutions to ensure a successful product launch. 

Mr. Kerchner brings to Aphena a track record of accomplishments at companies ranging from Fortune 500 companies to private equity-backed companies. His focus is on team development, improving margins and revenue growth. 

Prior to coming on board with Aphena Pharma, Mr. Kerchner was the President and COO of Lumberton, NJ-based Sancoa International, a private-equity owned label and tube supplier for the HBA market. Mr. Kerchner also worked as CEO of Medicia Holdings, LLC in Dayton, NJ, president of Gilbreth Packaging (now a part of Cenveo) in Croydon, PA, and was the vice president and general manager of Custom Extrusion Technologies (CET Films)/IGI in Lakewood, NJ. Previously, he has worked for VPI, LLC., Russell-Stanley Corporation, Jefferson Smurfit Group, and Johnson Matthey, PLC. 

"We strongly believe that Kevin's proven experience as an accomplished leader will enhance Aphena's abilities to achieve its goals," said Bob Allen, Executive Chairman for Aphena Pharma Solutions, Inc. 

"I am happy to be joining such a great organization," said Mr. Kerchner. "Aphena's culture and commitment to development and excellence confirms my confidence in partnering with this industry leader." 

About Aphena Pharma Solutions:

Aphena Pharma Solutions, Inc. specializes in providing quality, compliant pharmaceutical packaging and manufacturing services by exceeding customer expectations through strong teamwork, empowered employees and continuous improvement. Aphena was formed by a family of well-established, seasoned companies (PrePak Systems, TestPak, Celeste, Classic and Integrated Pharmaceutical Packaging). Several of these organizations have been in this industry for over 25 years. Aphena has five FDA-registered facilities in the U.S. and offers customers several capabilities. The products Aphena is actively handling include solid dose, liquids, gels, creams, ointments, foams, suspensions and lotions.

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.